Peter Vickerman

26.1k total citations · 10 hit papers
394 papers, 14.6k citations indexed

About

Peter Vickerman is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Peter Vickerman has authored 394 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 316 papers in Epidemiology, 194 papers in Infectious Diseases and 174 papers in Hepatology. Recurrent topics in Peter Vickerman's work include HIV, Drug Use, Sexual Risk (235 papers), HIV/AIDS Research and Interventions (181 papers) and Hepatitis C virus research (171 papers). Peter Vickerman is often cited by papers focused on HIV, Drug Use, Sexual Risk (235 papers), HIV/AIDS Research and Interventions (181 papers) and Hepatitis C virus research (171 papers). Peter Vickerman collaborates with scholars based in United Kingdom, United States and Canada. Peter Vickerman's co-authors include Matthew Hickman, Natasha K. Martin, Louisa Degenhardt, Katy Turner, Sharon Hutchinson, Jason Grebely, Katharine J Looker, Jack Stone, Sami L. Gottlieb and Sarah Larney and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Vickerman

370 papers receiving 14.2k citations

Hit Papers

Global prevalence of injecting drug use and sociodemogra... 2012 2026 2016 2021 2017 2019 2016 2015 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
    2017 996 citations Louisa Degenhardt, Amy Peacock et al. The Lancet Global Health profile →
  2. Global patterns of opioid use and dependence: harms to populations, interventions, and future action
    2019 496 citations Louisa Degenhardt, Jason Grebely et al. profile →
  3. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
    2016 485 citations Lucy Platt, Peter Vickerman et al. profile →
  4. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012
    2015 458 citations Peter Vickerman et al. profile →
  5. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
    2013 368 citations Natasha K. Martin, Peter Vickerman et al. profile →
  6. Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
    2015 368 citations Peter Vickerman et al. profile →
  7. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
    2012 359 citations Natasha K. Martin, Peter Vickerman et al. BMJ profile →
  8. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
    2017 293 citations Amy Peacock, Matthew Hickman et al. The Lancet Global Health profile →
  9. How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity
    2018 257 citations Matthew Quaife, Fern Terris‐Prestholt et al. profile →
  10. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review
    2023 109 citations Louisa Degenhardt, Paige Webb et al. The Lancet Global Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Vickerman United Kingdom 56 11.4k 5.6k 5.5k 2.8k 1.9k 394 14.6k
Margaret Hellard Australia 58 8.3k 0.7× 5.9k 1.1× 4.1k 0.8× 1.0k 0.4× 1.9k 1.0× 594 13.9k
Kenrad E. Nelson United States 73 11.3k 1.0× 6.2k 1.1× 8.3k 1.5× 1.8k 0.7× 1.4k 0.7× 372 18.6k
Mark Tyndall Canada 74 12.6k 1.1× 2.4k 0.4× 6.5k 1.2× 5.3k 1.9× 3.4k 1.8× 263 16.2k
Lisa Maher Australia 53 7.5k 0.7× 2.8k 0.5× 3.1k 0.6× 2.2k 0.8× 2.7k 1.4× 375 10.7k
Laith J. Abu‐Raddad Qatar 50 5.8k 0.5× 2.1k 0.4× 4.4k 0.8× 1.6k 0.6× 736 0.4× 299 11.7k
Maria Prins Netherlands 53 6.0k 0.5× 3.6k 0.7× 4.5k 0.8× 631 0.2× 968 0.5× 340 10.2k
Geraldine M. McQuillan United States 51 11.4k 1.0× 6.6k 1.2× 2.5k 0.5× 1.3k 0.5× 351 0.2× 92 17.7k
Kimberly Page United States 49 5.2k 0.5× 2.2k 0.4× 3.6k 0.6× 1.0k 0.4× 1.2k 0.6× 213 8.5k
Martin T. Schechter Canada 67 8.5k 0.7× 925 0.2× 5.8k 1.1× 4.3k 1.5× 1.8k 0.9× 373 15.8k
Holly Hagan United States 50 8.2k 0.7× 4.4k 0.8× 3.8k 0.7× 1.9k 0.7× 1.2k 0.6× 190 9.7k

Countries citing papers authored by Peter Vickerman

Since Specialization
Citations

This map shows the geographic impact of Peter Vickerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vickerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vickerman more than expected).

Fields of papers citing papers by Peter Vickerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vickerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vickerman. The network helps show where Peter Vickerman may publish in the future.

Co-authorship network of co-authors of Peter Vickerman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vickerman. A scholar is included among the top collaborators of Peter Vickerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vickerman. Peter Vickerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leng, Trystan, Fernand Guédou, Luc Béhanzin, et al.. (2025). Potential impact and cost-effectiveness of oral HIV pre-exposure prophylaxis for men who have sex with men in Cotonou, Benin: a mathematical modelling study. The Lancet Global Health. 13(6). e1111–e1121. 1 indexed citations
2.
Price, Olivia, Paige Webb, Jason Grebely, et al.. (2025). Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review. Drug and Alcohol Dependence. 273. 112732–112732.
3.
4.
5.
Alamneh, Tesfa Sewunet, Josephine G. Walker, Aaron G. Lim, et al.. (2024). Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero‐surveys in 2007 and 2019. Journal of Viral Hepatitis. 31(11). 645–656. 2 indexed citations
6.
Vold, Jørn Henrik, Fatemeh Chalabianloo, Else‐Marie Løberg, et al.. (2023). The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial. Substance Abuse Treatment Prevention and Policy. 18(1). 25–25. 1 indexed citations
7.
Stone, Jack, Hannah Fraser, Josephine G. Walker, et al.. (2022). Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya. AIDS. 36(15). 2191–2201. 6 indexed citations
8.
Williams, Jack, Peter Vickerman, Emma Page, et al.. (2022). Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom. Cost Effectiveness and Resource Allocation. 20(1). 60–60. 5 indexed citations
9.
McCombe, Geoff, Davina Swan, John S. Lambert, et al.. (2022). Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis. SHILAP Revista de lepidopterología. 11(2). e35300–e35300. 3 indexed citations
10.
Cunningham, Evan B., Alice Wheeler, Behzad Hajarizadeh, et al.. (2022). Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy. 111. 103917–103917. 31 indexed citations
11.
Croxford, Sara, Zoë Ward, Rachel Ayres, et al.. (2022). Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern Ireland. International Journal of Drug Policy. 102. 103615–103615. 2 indexed citations
12.
Thom, Howard, Josephine G. Walker, Peter Vickerman, & William Hollingworth. (2021). Exploratory comparison of Healthcare costs and benefits of the UK’s Covid-19 response with four European countries. European Journal of Public Health. 31(3). 619–624. 11 indexed citations
13.
Marks, Charles, Zachary Bouck, Sonia Jain, et al.. (2021). The impact of recent homelessness on the provision of injection drug use initiation assistance among persons who inject drugs in Tijuana, Mexico and Vancouver, Canada. Drug and Alcohol Dependence. 225. 108829–108829. 4 indexed citations
14.
Roberts, Kirsty, John Macleod, Chris Metcalfe, et al.. (2020). Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care. BMJ. 368. m322–m322. 16 indexed citations
15.
16.
Sweeney, Sedona, Zoë Ward, Lucy Platt, et al.. (2019). Evaluating the cost‐effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction. 114(3). 560–570. 22 indexed citations
17.
Yang, Fan, Weiming Tang, Marcus Alexander, et al.. (2019). Pay-it-forward gonorrhea and chlamydia testing among men who have sex with men in China: a study protocol for a three-arm cluster randomized controlled trial. Infectious Diseases of Poverty. 8(1). 76–76. 7 indexed citations
18.
McCombe, Geoff, Davina Swan, Gordana Avramovic, et al.. (2018). Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care. JMIR Research Protocols. 7(6). e149–e149. 8 indexed citations
19.
Quaife, Matthew, et al.. (2016). Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting Demand. Value in Health. 19(7). A374–A374. 1 indexed citations
20.
Walker, Dawn‐Marie, et al.. (2000). Responding to HIV/AIDS in Belarus: The importance of early intervention. 6(2). 53–55. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Hellard Breakdown of academic impact, for papers by Kenrad E. Nelson Breakdown of academic impact, for papers by Mark Tyndall Breakdown of academic impact, for papers by Lisa Maher Breakdown of academic impact, for papers by Laith J. Abu‐Raddad Breakdown of academic impact, for papers by Maria Prins Breakdown of academic impact, for papers by Geraldine M. McQuillan Breakdown of academic impact, for papers by Kimberly Page Breakdown of academic impact, for papers by Martin T. Schechter Breakdown of academic impact, for papers by Holly Hagan
Rankless by CCL
2026